Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Acquisitions & Divestments (2024 - 2025)

Historic Change in Acquisitions & Divestments for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $71.0 million.

  • Beta Bionics' Change in Acquisitions & Divestments rose 19583.33% to $71.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $138.0 million, marking a year-over-year change of. This contributed to the annual value of $72.0 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Beta Bionics' Change in Acquisitions & Divestments stood at $71.0 million, which was up 19583.33% from $23.0 million recorded in Q2 2025.
  • Beta Bionics' 5-year Change in Acquisitions & Divestments high stood at $71.0 million for Q3 2025, and its period low was $8.0 million during Q1 2024.